DALE DELANEY: Open Payments
NPI 1942378922 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 48 payments from 14 companies in 2025. Trend: 2023 $1,478 · 2024 $1,259 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $275 |
| ABBVIE INC. | 10 | $147 |
| Lundbeck LLC | 4 | $95 |
| PFIZER INC. | 4 | $94 |
| Forte Bio-Pharma LLC | 3 | $78 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| SCILEX PHARMACEUTICALS INC. | 2 | $37 |
| PROTEGA PHARMACEUTIALS INC | 2 | $35 |
| Impel Pharmaceuticals LLC | 2 | $33 |
Products named: RELISTOR, VYEPTI, NURTEC ODT, PROLATE, QULIPTA, BOTOX, UBRELVY, Symbravo.
Industry payments across NV — which companies pay providers there.
